Ascierto, Paolo Antonio
Borgognoni, Lorenzo
Botti, Gerardo
Guida, Michele
Marchetti, Paolo
Mocellin, Simone
Muto, Paolo
Palmieri, Giuseppe
Patuzzo, Roberto
Quaglino, Pietro
Stanganelli, Ignazio
Caracò, Corrado
Article History
Received: 11 July 2019
Accepted: 3 August 2019
First Online: 14 August 2019
Change Date: 18 September 2019
Change Type: Correction
Change Details: Following publication of the original article [1], the authors reported that one of the authors, Corrado Caracò, has been accidentally omitted from the author list. In this Correction the author has been added to the author list.
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: PAA has/had a Consulting or Advisory Role for BMS, Roche-Genentech, MSD, Array, Novartis, Merck Serono, Pierre Fabre, Incyte, Genmab, Newlink Genetics, Medimmune, AstraZeneca, Syndax, Sun Pharma, Sanofi, Idera, Ultimovacs, Sandoz, Immunocore. He received also Research funds from BMS, Roche-Genentech, Array, and travel support from MSD.PQ participated to Advisory Boards for Novartis, BMS, Merck. The other authors have no competing interests directly relevant to this manuscript.